{"id":{"repo_id":"baylor","oai_identifier":"oai:baylor-ir.tdl.org:2104/10037"},"canonical_url":"https://search.dev.ndltd.org/etd/baylor/oai:baylor-ir.tdl.org:2104/10037","repository":{"repo_id":"baylor","name":"Baylor University","base_url":"https://baylor-ir.tdl.org/server/oai/request"},"display":{"title":"Bayesian methods in non-clinical pharmaceutical statistics.","abstract":"This dissertation is composed of three research papers investigating the application of Bayesian methods to pharmaceutical non-clinical statistics. In the first paper, we present an application of Bayesian assurance and sample size determination to the manufacturing process validation life-cycle. In particular, we show how the two-prior approach for sample size determination, which has been considered extensively in the clinical biostatistics area, can be applied to determine the number of commercial scale batches that are needed for Stage II of the process validation life-cycle. In the second paper, we propose a Bayesian methodology for estimation of resistance parameters used in the validation of steam sterilization processes for aseptic manufacturing of drug products. Since the assessment of the sterility of manufacturing equipment and product is fundamentally an assessment of probability, we show that a Bayesian approach permits validation conclusions to be made based on the quantification of the risk of non-sterility. Finally, in the third paper, we show how accelerated drug stability results can be used to inform long-term stability studies in the area of drug shelf-life determination using Bayesian methods.","abstract_html":"This dissertation is composed of three research papers investigating the application of Bayesian methods to pharmaceutical non-clinical statistics. In the first paper, we present an application of Bayesian assurance and sample size determination to the manufacturing process validation life-cycle. In particular, we show how the two-prior approach for sample size determination, which has been considered extensively in the clinical biostatistics area, can be applied to determine the number of commercial scale batches that are needed for Stage II of the process validation life-cycle. In the second paper, we propose a Bayesian methodology for estimation of resistance parameters used in the validation of steam sterilization processes for aseptic manufacturing of drug products. Since the assessment of the sterility of manufacturing equipment and product is fundamentally an assessment of probability, we show that a Bayesian approach permits validation conclusions to be made based on the quantification of the risk of non-sterility. Finally, in the third paper, we show how accelerated drug stability results can be used to inform long-term stability studies in the area of drug shelf-life determination using Bayesian methods.","abstract_has_math":false,"creators":["Faya, Paul. 1979-"],"institution":"Baylor University.","degree_name":"Ph.D.","degree_level":"Doctoral","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":["Stamey, James D.","Seaman, John Weldon, Jr., 1956-"],"committee_chairs":[],"committee_members":[],"year":2017,"date_issued":"2017-05","date_published":"2017-05","updated_at":"2026-07-24T01:08:00Z","subjects":["Bayesian.","Pharmaceuticals.","Sample size determination.","Process validation.","Stability.","Shelf-life.","Accelerated.","Non-clinical.","Hierarchical."],"languages":["en"],"rights":["Baylor University works are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. Contact libraryquestions@baylor.edu for inquiries about permission."],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2104/10037","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Stamey, James D.","Seaman, John Weldon, Jr., 1956-"]},{"key":"dc:creator","label":"Author","values":["Faya, Paul. 1979-"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2017-06-05T12:52:13Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2017-06-05T12:52:13Z"]},{"key":"dc:date.issued","label":"Date","values":["2017-05"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Doctoral"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Baylor University."]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Bayesian.","Pharmaceuticals.","Sample size determination.","Process validation.","Stability.","Shelf-life.","Accelerated.","Non-clinical.","Hierarchical."]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Baylor University works are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. Contact libraryquestions@baylor.edu for inquiries about permission."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2104/10037"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["This dissertation is composed of three research papers investigating the application of Bayesian methods to pharmaceutical non-clinical statistics. In the first paper, we present an application of Bayesian assurance and sample size determination to the manufacturing process validation life-cycle. In particular, we show how the two-prior approach for sample size determination, which has been considered extensively in the clinical biostatistics area, can be applied to determine the number of commercial scale batches that are needed for Stage II of the process validation life-cycle. In the second paper, we propose a Bayesian methodology for estimation of resistance parameters used in the validation of steam sterilization processes for aseptic manufacturing of drug products. Since the assessment of the sterility of manufacturing equipment and product is fundamentally an assessment of probability, we show that a Bayesian approach permits validation conclusions to be made based on the quantification of the risk of non-sterility. Finally, in the third paper, we show how accelerated drug stability results can be used to inform long-term stability studies in the area of drug shelf-life determination using Bayesian methods."]},{"key":"dc:format.mimetype","label":"Dc Format Mimetype","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Bayesian methods in non-clinical pharmaceutical statistics."]}]}],"canonical_facts":{"dc:contributor.advisor":["Stamey, James D.","Seaman, John Weldon, Jr., 1956-"],"dc:creator":["Faya, Paul. 1979-"],"dc:date.accessioned":["2017-06-05T12:52:13Z"],"dc:date.available":["2017-06-05T12:52:13Z"],"dc:date.issued":["2017-05"],"dc:description.abstract":["This dissertation is composed of three research papers investigating the application of Bayesian methods to pharmaceutical non-clinical statistics. In the first paper, we present an application of Bayesian assurance and sample size determination to the manufacturing process validation life-cycle. In particular, we show how the two-prior approach for sample size determination, which has been considered extensively in the clinical biostatistics area, can be applied to determine the number of commercial scale batches that are needed for Stage II of the process validation life-cycle. In the second paper, we propose a Bayesian methodology for estimation of resistance parameters used in the validation of steam sterilization processes for aseptic manufacturing of drug products. Since the assessment of the sterility of manufacturing equipment and product is fundamentally an assessment of probability, we show that a Bayesian approach permits validation conclusions to be made based on the quantification of the risk of non-sterility. Finally, in the third paper, we show how accelerated drug stability results can be used to inform long-term stability studies in the area of drug shelf-life determination using Bayesian methods."],"dc:format.mimetype":["application/pdf"],"dc:identifier.uri":["https://hdl.handle.net/2104/10037"],"dc:language.iso":["en"],"dc:rights":["Baylor University works are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. Contact libraryquestions@baylor.edu for inquiries about permission."],"dc:subject":["Bayesian.","Pharmaceuticals.","Sample size determination.","Process validation.","Stability.","Shelf-life.","Accelerated.","Non-clinical.","Hierarchical."],"dc:title":["Bayesian methods in non-clinical pharmaceutical statistics."],"dc:type":["Thesis"],"thesis:degree_level":["Doctoral"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["Baylor University."]},"updated_at":"2026-07-24T01:08:00Z"}